Identification of cytosolic aldehyde dehydrogenase 1 from non‐small cell lung carcinomas as a flavopiridol‐binding protein
Open Access
- 2 July 1999
- journal article
- Published by Wiley in FEBS Letters
- Vol. 454 (1-2) , 100-104
- https://doi.org/10.1016/s0014-5793(99)00773-5
Abstract
The synthetic flavone flavopiridol can be cytostatic or cytotoxic to mammalian cells, depending on the concentration of the drug and the duration of exposure. It has been shown to inhibit the cyclin‐...Keywords
This publication has 21 references indexed in Scilit:
- Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cellsInternational Journal of Cancer, 1998
- From Bench Top to BedsideScience, 1997
- Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.Proceedings of the National Academy of Sciences, 1996
- Principles of CDK regulationNature, 1995
- Mitosis in transitionCell, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275Biochemical and Biophysical Research Communications, 1994
- Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells: Correlation with decreased H1 kinase activityBiochemical Pharmacology, 1993
- Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275JNCI Journal of the National Cancer Institute, 1992